Influence of valproic acid on hepatic carbohydrate and lipid metabolism.
Valproic acid (dipropylacetic acid), an antiepileptic agent known to be hepatotoxic in some patients, caused inhibition of lactate gluconeogenesis, fatty acid oxidation, and fatty acid synthesis by isolated hepatocytes. The latter process was the most sensitive to valproic acid, 50% inhibition occurring at ca. 125 microM with cells from meal-fed female rats. The medium-chain acyl-CoA ester fraction was increased whereas coenzyme A (CoA), acetyl-CoA, and the long chain acyl-CoA fractions were decreased by valproic acid. The increase in the medium chain acyl-CoA fraction was found by high-pressure liquid chromatography to be due to the accumulation of valproyl-CoA plus an apparent CoAester metabolite of valproyl-CoA. Salicylate inhibited valproyl-CoA formation and partially protected against valproic acid inhibition of hepatic metabolic processes. Octanoate had a similar protective effect, suggesting that activation of valproic acid in the mitosol is required for its inhibitory effects. It is proposed that either valproyl-CoA itself or the sequestration of CoA causes inhibition of metabolic processes. Valproyl-CoA formation also appears to explain valproic acid inhibition of gluconeogenesis by isolated kidney tubules. No evidence was found for the accumulation of valproyl-CoA in brain tissue, suggesting that the effects of valproic acid in the central nervous system are independent of the formation of this metabolite.
D000217:Acyltransferases / Q000378:metabolism; D000818:Animals; D002210:Caprylates / Q000494:pharmacology; D050260:Carbohydrate Metabolism; D002333:Carnitine Acyltransferases / Q000378:metabolism; D003065:Coenzyme A / Q000378:metabolism; D005227:Fatty Acids / Q000096:biosynthesis; D005260:Female; D005943:Gluconeogenesis / Q000187:drug effects; D007657:Ketone Bodies / Q000096:biosynthesis; D050356:Lipid Metabolism; D008099:Liver / Q000187:drug effects* / Q000378:metabolism; D008930:Mitochondria, Liver / Q000187:drug effects; D019301:Oleic Acid; D009829:Oleic Acids / Q000494:pharmacology; D010101:Oxygen Consumption / Q000187:drug effects; D051381:Rats; D012459:Salicylates / Q000494:pharmacology; D020156:Salicylic Acid; D014635:Valproic Acid / Q000494:pharmacology*
D002210:Caprylates; D005227:Fatty Acids; D007657:Ketone Bodies; D009829:Oleic Acids; D012459:Salicylates; D019301:Oleic Acid; D014635:Valproic Acid; D000217:Acyltransferases; D002333:Carnitine Acyltransferases; C020680:glycine acyltransferase; D020156:Salicylic Acid; D003065:Coenzyme A